Slate Path Capital LP - Q1 2020 holdings

$1.3 Billion is the total value of Slate Path Capital LP's 26 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 55.6% .

 Value Shares↓ Weighting
GOLD BuyBARRICK GOLD CORPORATION$185,856,000
+2.1%
10,145,000
+3.6%
14.25%
+45.3%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$164,053,000
-11.2%
376,000
-1.3%
12.58%
+26.4%
MYL NewMYLAN NV$160,804,00010,785,000
+100.0%
12.33%
NYT SellNEW YORK TIMES COcl a$132,974,000
-16.2%
4,330,000
-12.2%
10.20%
+19.4%
SNAP SellSNAP INCcl a$113,966,000
-51.9%
9,585,000
-33.9%
8.74%
-31.5%
ALNY SellALNYLAM PHARMACEUTICALS INC$78,154,000
-16.7%
718,000
-11.9%
5.99%
+18.6%
Z SellZILLOW GROUP INCcl c cap stk$77,443,000
-42.4%
2,150,000
-26.5%
5.94%
-17.9%
MOS BuyMOSAIC CO NEW$70,817,000
-46.5%
6,545,000
+6.9%
5.43%
-23.9%
BHC SellBAUSCH HEALTH COS INC$65,798,000
-60.6%
4,245,000
-23.9%
5.05%
-43.9%
PAAS BuyPAN AMERN SILVER CORP$63,482,000
-25.6%
4,430,000
+23.1%
4.87%
+6.0%
KEX SellKIRBY CORP$56,337,000
-57.9%
1,296,000
-13.2%
4.32%
-40.0%
FCX BuyFREEPORT-MCMORAN INCcl b$50,828,000
-44.5%
7,530,000
+7.9%
3.90%
-21.0%
IRWD NewIRONWOOD PHARMACEUTICALS INC$13,521,0001,340,000
+100.0%
1.04%
ENDP BuyENDO INTL PLC$12,506,000
+661.6%
3,380,000
+865.7%
0.96%
+989.8%
CUE SellCUE BIOPHARMA INC$12,355,000
-12.6%
870,694
-2.2%
0.95%
+24.6%
EEM  ISHARES TRcall$11,365,000
-23.9%
333,0000.0%0.87%
+8.3%
QURE  UNIQURE NV$6,643,000
-33.8%
140,0000.0%0.51%
-5.7%
ZG  ZILLOW GROUP INCcl a$6,284,000
-25.7%
185,0000.0%0.48%
+5.7%
LX BuyLEXINFINTECH HLDGS LTDadr$3,903,000
+24.9%
440,000
+95.6%
0.30%
+78.0%
W NewWAYFAIR INCcl a$3,741,00070,000
+100.0%
0.29%
APRN SellBLUE APRON HLDGS INCcl a new$3,579,000
+69.9%
297,000
-7.2%
0.27%
+142.5%
ATRA NewATARA BIOTHERAPEUTICS INC$3,574,000420,000
+100.0%
0.27%
CYCN NewCYCLERION THERAPEUTICS INC$3,170,0001,196,063
+100.0%
0.24%
INTEQ  INTELSAT S A$1,683,000
-78.2%
1,100,0000.0%0.13%
-69.1%
RIG NewTRANSOCEAN LTD$545,000470,000
+100.0%
0.04%
ARCH NewARCH COAL INCcl a$520,00018,000
+100.0%
0.04%
X ExitUNITED STATES STL CORP NEW$0-40,000
-100.0%
-0.02%
SNAP ExitSNAP INCcall$0-110,000
-100.0%
-0.10%
AG ExitFIRST MAJESTIC SILVER CORP$0-170,000
-100.0%
-0.11%
TDW ExitTIDEWATER INC NEW$0-110,000
-100.0%
-0.11%
RETA ExitREATA PHARMACEUTICALS INCcl a$0-120,000
-100.0%
-1.32%
SBGL ExitSIBANYE STILLWATERsponsored adr$0-3,935,000
-100.0%
-2.10%
EQT ExitEQT CORP$0-4,970,000
-100.0%
-2.92%
MDCO ExitMEDICINES CO$0-818,042
-100.0%
-3.74%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings